Scavenger receptor family proteins: roles for atherosclerosis, host defence and disorders of the central nervous system

被引:200
|
作者
Yamada, Y [1 ]
Doi, T [1 ]
Hamakubo, T [1 ]
Kodama, T [1 ]
机构
[1] Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 153, Japan
关键词
macrophage; endothelial cell; atherosclerosis; lipoprotein metabolism; cholesterol; apoptosis; host defence; Alzheimer's disease;
D O I
10.1007/s000180050191
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this review, we summarize the structure and function of the scavenger receptor family of proteins including class A (type I and II macrophage scavenger receptors, MARCO), class B (CD36, scavenger receptor class BI), mucinlike (CD68/macrosialin. dSR-CI) and endothelial (LOX-1) receptors. Two motifs have been identified as ligand-binding domains: a charged collagen structure of type I and II receptors, and an immunodominant domain of CD36. These structures can recognize a wide range of negatively charged macromolecules, including oxidized low-density lipoproteins, damaged or apoptotic cells, and pathogenic microorganisms. After binding, these ligands can be either internalized by endocytosis or phagocytosis, or remain at the cell surface and mediate adhesion or lipid transfer through caveolae. Under physiological conditions, scavenger receptors serve to scavenge or clean up cellular debris and other related materials, and they play a role in host defence. In pathological states, they mediate the recruitment, activation and transformation of macrophages and other cells which may be related to the development of atherosclerosis and to disorders caused by the accumulation of denatured materials, such as Alzheimer's disease.
引用
收藏
页码:628 / 640
页数:13
相关论文
共 50 条
  • [41] Taurine and central nervous system disorders
    Menzie, Janet
    Pan, Chunliu
    Prentice, Howard
    Wu, Jang-Yen
    AMINO ACIDS, 2014, 46 (01) : 31 - 46
  • [42] The microbiome and disorders of the central nervous system
    Felice, Valeria D.
    O'Mahony, Siobhain M.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2017, 160 : 1 - 13
  • [43] Inflammatory disorders of the central nervous system
    Giovannoni, G
    Baker, D
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (03) : 347 - 350
  • [44] Chemokines and central nervous system disorders
    William J. Karpus
    Journal of NeuroVirology, 2001, 7 : 493 - 500
  • [45] Mercury and central nervous system disorders
    Fung, YK
    Meade, AG
    Rack, E
    Blotcky, AJ
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 158 - 158
  • [46] Venous disorders of the central nervous system
    Willinsky, RA
    NEUROIMAGING CLINICS OF NORTH AMERICA, 2003, 13 (01) : XI - XI
  • [47] Proteins of the central nervous system.
    McGregor, HH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1917, 28 (02) : 403 - 427
  • [48] Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders
    Pechlivanidou, Maria
    Vakrakou, Aigli G.
    Karagiorgou, Katerina
    Tuezuen, Erdem
    Karachaliou, Eleni
    Chroni, Elisabeth
    Afrantou, Theodora
    Grigoriadis, Nikolaos
    Argyropoulou, Christina
    Paschalidis, Nikolaos
    Sanli, Elif
    Tsantila, Aikaterini
    Dandoulaki, Maria
    Ninou, Elpinickie I.
    Zisimopoulou, Paraskevi
    Mantegazza, Renato
    Andreetta, Francesca
    Dudeck, Leon
    Steiner, Johann
    Lindstrom, Jon Martin
    Tzanetakos, Dimitrios
    Voumvourakis, Konstantinos
    Giannopoulos, Sotirios
    Tsivgoulis, Georgios
    Tzartos, Socrates J.
    Tzartos, John
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] Roles of FAK family kinases in nervous system
    Xiong, WC
    Mei, L
    FRONTIERS IN BIOSCIENCE, 2003, 8 : S676 - S682
  • [50] CNR family in the central nervous system
    Yagi, T
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 6A - 6A